Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace Callagy

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Nodal-stage classification in invasive lobular breast carcinoma: influence of different interpretations of the pTNM classificationCarolien H M van Deurzen, Gabor Cserni, Simonetta Bianchi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancerAyaka Katayama, Islam M Miligy, Sho Shiino, et al.
Cancers|September 10, 2021
Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast CancerDarren Kilmartin, Mark O'Loughlin, Xavier Andreu, et al.
Cancers|July 20, 2019
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional StudyShristi Bhattarai, Sergey Klimov, Karuna Mittal, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2026
Margin Adequacy in Phyllodes Tumours Revisited: Reappraisal of the Evidence Base and Knowledge GapsEmad A Rakha, Cecily Quinn, Gelareh Farshid, et al.
Cancers|February 25, 2023
ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its LimitationsBálint Cserni, Darren Kilmartin, Mark O'Loughlin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 30, 2025
International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow CategoriesEmad A Rakha, Puay Hoon Tan, Mieke R Van Bockstal, et al.
Histopathology|April 14, 2025
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteriaPuay Hoon Tan, Ian O Ellis, Kimberly H Allison, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2025
Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further ManagementEmad A Rakha, Cecily Quinn, Wendy Raymond, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Nodal-stage classification in invasive lobular breast carcinoma: influence of different interpretations of the pTNM classificationCarolien H M van Deurzen, Gabor Cserni, Simonetta Bianchi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancerAyaka Katayama, Islam M Miligy, Sho Shiino, et al.
Cancers|September 10, 2021
Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast CancerDarren Kilmartin, Mark O'Loughlin, Xavier Andreu, et al.
Cancers|July 20, 2019
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional StudyShristi Bhattarai, Sergey Klimov, Karuna Mittal, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2026
Margin Adequacy in Phyllodes Tumours Revisited: Reappraisal of the Evidence Base and Knowledge GapsEmad A Rakha, Cecily Quinn, Gelareh Farshid, et al.
Cancers|February 25, 2023
ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its LimitationsBálint Cserni, Darren Kilmartin, Mark O'Loughlin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 30, 2025
International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow CategoriesEmad A Rakha, Puay Hoon Tan, Mieke R Van Bockstal, et al.
Histopathology|April 14, 2025
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteriaPuay Hoon Tan, Ian O Ellis, Kimberly H Allison, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2025
Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further ManagementEmad A Rakha, Cecily Quinn, Wendy Raymond, et al.
Pageof 4